Health Trials

Advanced Solid Tumors (Phase 1)

2

Review clinical trials related to Advanced Solid Tumors (Phase 1). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Safety and Tolerability Evaluation of CEL001 Injection in Advanced Solid Tumors

This study is the first human, open label, dose escalation, and expansion phase I clinical trial aimed at evaluating the safety, tolerability, preliminary efficacy, pharmacokinetic characteristics, biomarker changes, and immunogenicity of CEL001 injection in the treatment of advanced solid tumors.

Participants needed: 13
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Guangzhou Xiling Biotechnology Co., Ltd.Updated: Dec 2, 2025Locations: 1
Eligibility criteria

Age ≥ 18 years old, gender not limited; [+19]

Individuals allergic to any component of CEL001 injection, including those aller... [+14]

Read more
Status: Not yet recruiting

A Phase I Study OfLNF2007 Monotherapy in Patients with Advanced Solid Tumors

A non-randomized, open-ended, phase I dose-escalation and dose-expansion study was designed to evaluate the safety, tolerability, antitumor efficacy, PK and immunogenic characteristics of LNF2007 in patients with advanced solid tumors

Participants needed: 94
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Shandong New Time Pharmaceutical Co., LTDUpdated: Dec 30, 2024
Eligibility criteria

Age ≥18 years old, gender unlimited; [+8]

Received any antitumor therapy within 4 weeks prior to the first use of the inve... [+15]

Read more